Virtus ETF Advisers’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,975
| Closed | -$378K | – | 446 |
|
|
2024
Q4 | $378K | Sell |
10,975
-92
| -0.8% | -$3.17K | 0.15% | 189 |
|
|
2024
Q3 | $443K | Hold |
11,067
| – | – | 0.21% | 190 |
|
|
2024
Q2 | $334K | Sell |
11,067
-213
| -2% | -$6.43K | 0.16% | 206 |
|
|
2024
Q1 | $379K | Buy |
11,280
+1,623
| +17% | +$54.5K | 0.2% | 201 |
|
|
2023
Q4 | $312K | Buy |
9,657
+1,147
| +13% | +$37K | 0.2% | 220 |
|
|
2023
Q3 | $279K | Sell |
8,510
-1,099
| -11% | -$36K | 0.17% | 209 |
|
|
2023
Q2 | $338K | Buy |
9,609
+4,361
| +83% | +$153K | 0.2% | 170 |
|
|
2023
Q1 | $171K | Buy |
5,248
+89
| +2% | +$2.91K | 0.09% | 315 |
|
|
2022
Q4 | $284K | Sell |
5,159
-137
| -3% | -$7.55K | 0.15% | 291 |
|
|
2022
Q3 | $235K | Buy |
5,296
+78
| +1% | +$3.46K | 0.09% | 301 |
|
|
2022
Q2 | $254K | Sell |
5,218
-4,468
| -46% | -$217K | 0.09% | 294 |
|
|
2022
Q1 | $471K | Hold |
9,686
| – | – | 0.21% | 131 |
|
|
2021
Q4 | $413K | Sell |
9,686
-4,605
| -32% | -$196K | 0.16% | 139 |
|
|
2021
Q3 | $548K | Sell |
14,291
-1,312
| -8% | -$50.3K | 0.24% | 124 |
|
|
2021
Q2 | $440K | Buy |
15,603
+281
| +2% | +$7.92K | 0.18% | 184 |
|
|
2021
Q1 | $506K | Buy |
15,322
+423
| +3% | +$14K | 0.21% | 145 |
|
|
2020
Q4 | $539K | Buy |
+14,899
| New | +$539K | 0.22% | 136 |
|